Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Decreased by Bank Julius Baer & Co. Ltd Zurich

Bank Julius Baer & Co. Ltd Zurich decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 763,659 shares of the medical equipment provider's stock after selling 13,248 shares during the period. Intuitive Surgical makes up 1.4% of Bank Julius Baer & Co. Ltd Zurich's portfolio, making the stock its 19th biggest holding. Bank Julius Baer & Co. Ltd Zurich owned 0.22% of Intuitive Surgical worth $257,628,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Portside Wealth Group LLC lifted its stake in Intuitive Surgical by 8.2% during the fourth quarter. Portside Wealth Group LLC now owns 816 shares of the medical equipment provider's stock valued at $275,000 after buying an additional 62 shares in the last quarter. Sequoia Financial Advisors LLC lifted its stake in Intuitive Surgical by 58.0% during the fourth quarter. Sequoia Financial Advisors LLC now owns 8,315 shares of the medical equipment provider's stock valued at $2,805,000 after buying an additional 3,054 shares in the last quarter. Kades & Cheifetz LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $230,000. Blair William & Co. IL lifted its position in shares of Intuitive Surgical by 3.1% in the third quarter. Blair William & Co. IL now owns 377,371 shares of the medical equipment provider's stock worth $110,302,000 after purchasing an additional 11,400 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its position in shares of Intuitive Surgical by 21.2% in the third quarter. Assenagon Asset Management S.A. now owns 739,471 shares of the medical equipment provider's stock worth $216,140,000 after purchasing an additional 129,194 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ISRG. BTIG Research increased their price target on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a "buy" rating in a research report on Friday, April 19th. Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an "outperform" rating in a research report on Wednesday, January 24th. Jefferies Financial Group increased their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a "hold" rating in a research report on Friday, April 19th. Citigroup increased their price objective on Intuitive Surgical from $428.00 to $462.00 and gave the stock a "buy" rating in a report on Wednesday, April 3rd. Finally, Stifel Nicolaus increased their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the stock a "buy" rating in a report on Monday, April 8th. Five research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $396.17.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded down $1.89 during trading hours on Thursday, hitting $373.12. 1,262,491 shares of the stock were exchanged, compared to its average volume of 1,667,548. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $403.76. The company's 50 day moving average is $386.40 and its 200 day moving average is $345.19. The firm has a market capitalization of $132.35 billion, a P/E ratio of 67.58, a P/E/G ratio of 4.83 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating analysts' consensus estimates of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same period in the prior year, the firm earned $1.00 EPS. The business's revenue was up 11.5% on a year-over-year basis. Research analysts anticipate that Intuitive Surgical, Inc. will post 4.84 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Alan J. Levy sold 2,000 shares of the stock in a transaction on Friday, January 26th. The shares were sold at an average price of $370.20, for a total value of $740,400.00. Following the completion of the transaction, the director now owns 25,319 shares in the company, valued at approximately $9,373,093.80. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, VP Marshall Mohr sold 108,790 shares of the stock in a transaction dated Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the completion of the sale, the vice president now owns 26,877 shares in the company, valued at approximately $10,349,795.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.20, for a total transaction of $740,400.00. Following the sale, the director now owns 25,319 shares of the company's stock, valued at approximately $9,373,093.80. The disclosure for this sale can be found here. Insiders sold a total of 255,736 shares of company stock valued at $98,639,667 in the last ninety days. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.